Global Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 23-Nov-2020
No. of pages: 115

According to this study, over the next five years the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market will register a 5.4%% CAGR in terms of revenue, the global market size will reach $ 8982.8 million by 2025, from $ 7291.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics, covering the supply chain analysis, impact assessment to the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Oral Therapy

- Injectable Therapy

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Hospitals & Clinics

- Home Settings

- Ambulatory Surgical Centers (ASCs)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Astellas Inc.

- Johnson & Johnson

- Dendreon Corporation

- Bayer AG

- Sanofi S.A

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market by identifying its various subsegments.

- Focuses on the key global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2025
2.1.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size CAGR by Region
2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Segment by Type
2.2.1 Oral Therapy
2.2.2 Oral Therapy
2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
2.3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
2.3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type (2015-2020)
2.4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Home Settings
2.4.3 Ambulatory Surgical Centers (ASCs)
2.5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
2.5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
2.5.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Application (2015-2020)

3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Players
3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Players
3.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Players (2018-2020)
3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Players (2018-2020)
3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Regions
4.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions
4.2 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
4.3 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
4.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
4.5 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth

5 Americas
5.1 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries
5.2 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
5.3 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions
6.2 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
6.3 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Countries
7.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
7.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Countries
8.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
8.3 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast
10.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2021-2025)
10.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Regions
10.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Type
10.8 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Astellas Inc.
11.1.1 Company Details
11.1.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
11.1.3 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Astellas Inc. News
11.2 Johnson & Johnson
11.2.1 Company Details
11.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
11.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Johnson & Johnson News
11.3 Dendreon Corporation
11.3.1 Company Details
11.3.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
11.3.3 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Dendreon Corporation News
11.4 Bayer AG
11.4.1 Company Details
11.4.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
11.4.3 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bayer AG News
11.5 Sanofi S.A
11.5.1 Company Details
11.5.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
11.5.3 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Sanofi S.A News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral Therapy
Table 5. Major Players of Injectable Therapy
Table 6. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Table 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
Table 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Players (2018-2020)
Table 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Products Offered
Table 13. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions 2015-2020
Table 18. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020)
Table 20. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Table 22. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
Table 24. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions (2015-2020)
Table 26. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Table 28. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
Table 30. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020)
Table 32. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Table 34. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics
Table 43. Key Application and Potential Industries of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics
Table 44. Key Challenges of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics
Table 45. Key Trends of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics
Table 46. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Regions
Table 48. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Application (2021-2025)
Table 52. Astellas Inc. Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors
Table 53. Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
Table 54. Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E)
Table 55. Astellas Inc. Main Business
Table 56. Astellas Inc. Latest Developments
Table 57. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors
Table 58. Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E)
Table 61. Johnson & Johnson Latest Developments
Table 62. Dendreon Corporation Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors
Table 63. Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
Table 64. Dendreon Corporation Main Business
Table 65. Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E)
Table 66. Dendreon Corporation Latest Developments
Table 67. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors
Table 68. Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
Table 69. Bayer AG Main Business
Table 70. Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E)
Table 71. Bayer AG Latest Developments
Table 72. Sanofi S.A Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors
Table 73. Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
Table 74. Sanofi S.A Main Business
Table 75. Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E)
Table 76. Sanofi S.A Latest Developments

List of Figures

Figure 1. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
Figure 5. Global Oral Therapy Market Size Growth Rate
Figure 6. Global Injectable Therapy Market Size Growth Rate
Figure 7. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Hospitals & Clinics
Figure 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Hospitals & Clinics (2015-2020) ($ Millions)
Figure 9. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Home Settings
Figure 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Home Settings (2015-2020) ($ Millions)
Figure 11. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Ambulatory Surgical Centers (ASCs)
Figure 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Ambulatory Surgical Centers (ASCs) (2015-2020) ($ Millions)
Figure 13. Global Ambulatory Surgical Centers (ASCs) YoY Growth ($ Millions)
Figure 14. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019
Figure 15. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions 2015-2020
Figure 16. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions)
Figure 17. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions)
Figure 18. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions)
Figure 20. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019
Figure 21. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019
Figure 22. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019
Figure 23. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions in 2019
Figure 27. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019
Figure 28. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019
Figure 29. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 33. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019
Figure 36. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019
Figure 37. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019
Figure 38. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 39. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019
Figure 47. Egypt Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 54. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 55. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 57. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 58. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 59. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 60. Brazil Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 61. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 62. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 63. Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 65. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 66. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 67. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 68. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 69. UK Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 70. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 71. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 72. Spain Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 73. Egypt Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 74. South Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 75. Israel Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 76. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)
  • Global Small Molecule Targeted Cancer Therapy Market Growth (Status and Outlook) 2020-2025
    Published: 15-Jan-2021        Price: US 3660 Onwards        Pages: 116
    According to this study, over the next five years the Small Molecule Targeted Cancer Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Small Molecule Targeted Cancer Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Small ......
  • Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2021-2027
    Published: 12-Jan-2021        Price: US 3900 Onwards        Pages: 90
    Small Molecule Targeted Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Monoclonal A......
  • Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027
    Published: 12-Jan-2021        Price: US 3900 Onwards        Pages: 99
    T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - CAR-T - TCR - TIL Therapies ......
  • Sezary Syndrome - Global Clinical Trials Review, H1, 2021
    Published: 08-Jan-2021        Price: US 2500 Onwards        Pages: 165
    Sezary Syndrome - Global Clinical Trials Review, H1, 2021 Summary GlobalData's clinical trial report, "Sezary Syndrome - Global Clinical Trials Review, H1, 2021" provides an overview of Sezary Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease cl......
  • Global Cancer Immunomodulator Market Research Report 2021
    Published: 31-Dec-2020        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Method of Use:CoQ10 - Method of Use:Levamisole Coating Agent Segment by Application - Hospit......
  • Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2029
    Published: 30-Dec-2020        Price: US 10995 Onwards        Pages: 181
    Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2029 Summary Non-small cell lung cancer (NSCLC) is currently the most common cancer in the world and is the leading cause of cancer mortality in men and women. Of total lung cancer incident cases, approximately 85% are the NSCLC subtype. NSCLC patients are usually diagnosed in the later stages of the disease, resulting in a poor prognosis. Since the last global market forecast (2015-2025), there ha......
  • Global Cancer Immunotherapies Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 29-Dec-2020        Price: US 3500 Onwards        Pages: 129
    Cancer immunotherapy is a therapy for treating cancer patients involved in or using components of the immune system. Some cancer immunotherapy consists of antibodies that bind to and inhibit the function of proteins expressed by cancer cells. Other cancer immunotherapies include vaccines and T cell infusions Based on the Cancer Immunotherapies market development status, competitive landscape and development model in different regions of the world, this report is dedicated to provi......
  • Global Melanoma Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 29-Dec-2020        Price: US 3660 Onwards        Pages: 118
    According to this study, over the next five years the Melanoma Therapeutics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Melanoma Therapeutics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Melanoma Therapeutics market by product ......
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 24-Dec-2020        Price: US 3900 Onwards        Pages: 98
    Melanoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Chemothe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs